The primary objective of the study is to evaluate the efficacy in wrinkle reduction of a single treatment of three different doses of botulinum toxin compared to placebo, in the treatment of moderate to very severe glabellar frown lines.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
359
Private practice
Birmingham, Alabama, United States
Private practice
Mobile, Alabama, United States
Private practice
San Diego, California, United States
Private practice
Englewood, Colorado, United States
Reduction of glabellar frown line severity on Day 14 following treatment with botulinum toxin
Reduction in glabellar frown line severity is derived separately for the Investigator and the subject assessment, using a validated photo scale, at maximum frown on Day 14.
Time frame: 14 Days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Private practice
Aventura, Florida, United States
Private practice
Nashville, Tennessee, United States
Private practice
San Antonio, Texas, United States
Private practice
Salt Lake City, Utah, United States